کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
6786860 1432451 2018 4 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Depression and Pharmacogenetics
ترجمه فارسی عنوان
افسردگی و فارماکوهنژیک
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی روانپزشکی و بهداشت روانی
چکیده انگلیسی
Depression is the most common and leading devastating psychiatric illness that affects a majority of the world population. The treatment of depression has been a challenge for a majority of patients and healthcare practitioners. The advent of pharmacogenomics (PGx) empowered the Food and Drug Administration to approve some antidepressant biomarkers for PGx model of treatment. The PGx testing identifies whether an individual is a poor metabolizer, ultra/rapid metabolizer, intermediate metabolizer, or essential metabolizer of an antidepressants before prescription. This is a cutting edge treatment that eliminates trial and error. PGx testing has shown to precisely identify the effective medication and dose for a patient.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Archives of Psychiatric Nursing - Volume 32, Issue 1, February 2018, Pages 71-74
نویسندگان
, , ,